Multi-arm PEG Modifier for L-asparaginase Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PEG modification methods for multimeric proteins, such as L-asparaginase, face challenges including reduced stability, bioactivity loss, and increased immunogenicity due to depolymerization of subunits, which are not effectively addressed by existing technologies.
Innovation Solution
The use of a multi-arm PEG modifier, specifically 4-arm PEG succinimidyl acetate or propionaldehyde, is conjugated to the amino groups of multimeric proteins to enhance subunit interaction and stability, preventing depolymerization and maintaining bioactivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If conventional linear PEG modifiers are used for protein PEGylation, then the in-vivo circulation half-life is extended and antigenicity is reduced, but the protein activity is significantly reduced (to 30-40% or even lower)
Solution Approach 1:
The patent uses multi-arm PEG modifiers (4-arm, 6-arm, 8-arm) with specific molecular weights (5k, 10k, 20k, 40k) to create composite PEGylated proteins. The multi-arm structure provides multiple attachment points for proteins, forming a composite material that maintains protein activity while extending circulation half-life. This resolves the contradiction by creating a new composite structure that simultaneously achieves both goals.
Solution Approach 2:
The patent systematically varies key parameters including PEG molecular weight (5k-40k), arm number (4, 6, 8), and protein-to-PEG molar ratios (1:5 to 1:200) to optimize the balance between circulation half-life and protein activity. By changing these parameters, the patent finds optimal conditions where both circulation time and activity are improved compared to conventional linear PEGylation.
2Duration of action of stationary object
If the molecular weight of PEG is increased to extend circulation half-life, then the in-vivo circulation half-life is improved, but the protein activity decreases much considerably
Solution Approach 1:
The patent creates composite structures using multi-arm PEG modifiers where multiple lower molecular weight PEG arms (e.g., four 5k PEG arms in 4-arm PEG 20k) collectively provide extended circulation half-life while maintaining better protein activity than equivalent linear PEG of the same total molecular weight. The branched architecture reduces steric hindrance and maintains protein conformation.
Solution Approach 2:
The patent transitions from linear one-dimensional PEG chains to multi-dimensional branched structures with 4, 6, or 8 arms radiating from a central core. This dimensional change allows the PEG cloud to extend further from the protein surface, providing better steric protection and extended circulation half-life while maintaining protein accessibility and activity.
3Duration of action of stationary object
If PEG modification is applied to multimeric proteins, then the in-vivo circulation half-life is extended, but depolymerization of subunits occurs leading to increased immunogenicity
Solution Approach 1:
The patent uses multi-arm PEG modifiers to merge multiple protein subunits into a single PEGylated complex. The multiple arms of the PEG modifier simultaneously attach to multiple subunits, creating a unified structure that prevents depolymerization. This merging approach maintains the integrity of multimeric proteins while extending their circulation half-life and reducing immunogenicity.
Solution Approach 2:
The patent creates composite structures where multi-arm PEG modifiers bridge multiple protein subunits together. This composite material approach forms a stable network that prevents subunit dissociation, thereby preventing the exposure of cryptic epitopes that would otherwise trigger immune responses. The composite structure simultaneously achieves extended circulation and reduced immunogenicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The multi-arm PEG modification significantly improves the stability and bioactivity of multimeric proteins, reducing immunogenicity and extending the in vivo half-life, as demonstrated by enhanced thermal stability and retained activity compared to conventional PEGylated products.
Implementation Method 1
Covalent modification of a protein with PEG (PEGylation) can increase the in-vivo circulation half-life, reduce the antigenicity, enhance the solubility, and alter the biodistribution in human of the protein
Data Source
AI summary
Methods for use of a multi-arm polyethylene glycol (PEG) modifier in modification of asparaginase. The described multi-arm PEG modifier enhances the subunit interaction of a multimeric protein to maintain the multimeric protein in a polymerized form, thereby improving the stability of the multimeric protein, maintaining the bioactivity of the multimeric protein, and reducing the probability of exposure of the antigen binding site after depolymerization of the subunits, so as to reduce the immunogenicity.